Mesenchymal stromal cells (MSC) have excellent clinical potential and numerous properties that ease its clinical translation. Mitochondria play a crucial role in energy metabolism, essential for cellular activities, such as proliferation, differentiation, and migration. However, mitochondrial dysfunction can occur due to diseases and pathological conditions. Research on mitochondrial transfer from MSCs to recipient cells has gained prominence. Numerous studies have demonstrated that mitochondrial transfer led to increased adenosine triphosphate (ATP) production, recovered mitochondrial bioenergetics, and rescued injured cells from apoptosis. However, the complex mechanisms that lead to mitochondrial transfer from healthy MSCs to damaged cells remain under investigation, and the factors contributing to mitochondrial bioenergetics recovery in recipient cells remain largely ambiguous. Therefore, this review demonstrates an overview of recent findings in preclinical studies reporting MSC mitochondrial transfer, comprised of information on cell sources, recipient cells, dosage, route of administration, mechanism of transfer, pathological conditions, and therapeutic effects. Further to the above, this research discusses the potential challenges of this therapy in its clinical settings and suggestions to overcome its challenges.
Platelet-rich plasma (PRP) is a well-established biological product used in
the tissue engineering field to promote wound healing and tissue regeneration. PRP can
form platelet gel with the addition of thrombin and/or calcium salts. Nonetheless, PRP
is more commonly combined with biomaterial and cells for various tissue engineering
applications. Over the years, PRP has been used in the dermatology field for hair
follicle regeneration and wound healing, in the orthopaedic field for bone, muscle,
tendon, and ligament repair, and in dentistry for many dental procedures, including
dental implants. Despite the long historical use of PRP in the clinic, the PRP isolation
technique is still continuously changing, evolving, and improving to increase the
therapeutic effect of PRP. Nowadays, PRP is not only used as a biomaterial but it also
can be used to replace foetal bovine serum and human serum in primary cell culture,
especially for cell therapy purposes. PRP derivatives such as platelet lysate, platelet.derived growth factors, and platelet-derived extracellular vesicles also are precious
functional materials used clinically in the tissue engineering field. In this book chapter,
we review the different subclasses of PRP, including its derivatives, its research, and
clinical applications, and underline the challenges of PRP in clinical translations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.